-+ 0.00%
-+ 0.00%
-+ 0.00%

Citigroup Maintains Neutral on Qiagen, Raises Price Target to $45

Benzinga·08/10/2026 14:34:10
Listen to the news
Citigroup analyst Brendan Digan maintains Qiagen (NYSE:QGEN) with a Neutral and raises the price target from $38 to $45.